First National Bank of Omaha’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-38,462
Closed -$4.45M 326
2023
Q3
$4.45M Sell
38,462
-6,418
-14% -$742K 0.29% 110
2023
Q2
$4.62M Sell
44,880
-1,771
-4% -$182K 0.27% 120
2023
Q1
$5.09M Sell
46,651
-55,282
-54% -$6.03M 0.31% 110
2022
Q4
$11.6M Sell
101,933
-2,533
-2% -$288K 0.72% 34
2022
Q3
$6.47M Buy
104,466
+8,525
+9% +$528K 0.42% 76
2022
Q2
$7.65M Buy
95,941
+14,625
+18% +$1.17M 0.46% 66
2022
Q1
$8.56M Buy
81,316
+12,761
+19% +$1.34M 0.44% 72
2021
Q4
$7.39M Sell
68,555
-3,234
-5% -$348K 0.35% 86
2021
Q3
$7.86M Sell
71,789
-3,636
-5% -$398K 0.4% 74
2021
Q2
$6.94M Hold
75,425
0.36% 91
2021
Q1
$6.94M Buy
75,425
+524
+0.7% +$48.2K 0.36% 91
2020
Q4
$5.48M Sell
74,901
-19,989
-21% -$1.46M 0.3% 111
2020
Q3
$7.37M Buy
94,890
+2,534
+3% +$197K 0.46% 71
2020
Q2
$5.13M Buy
+92,356
New +$5.13M 0.34% 96